TLR2 and irritable bowel syndrome: Mast cells, which express toll-like receptors 2 (TLR2) and TLR4, are activated by increased levels of fecal and serum lipopolysaccharides (LPS) in IBS, triggering the release of inflammatory mediators like histamine, tryptase, and prostaglandin E2 [81].